XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
RESEARCH AND DEVELOPMENT EXPENSES
 12 Months Ended
Dec. 31, 2022
RESEARCH AND DEVELOPMENT EXPENSES  
RESEARCH AND DEVELOPMENT EXPENSES

NOTE 21 – RESEARCH AND DEVELOPMENT EXPENSES

 

Research and development expenses, excluding stock-based compensation, depreciation and lease amortization expenses, allocated to our major research and development programs are as follows:

 

In Thousands of US Dollars

 

 

For the Year Ended December 31,

 

Research and Development Program

 

2022

 

 

2021

 

 

2020

 

Research and Development Program

 

$-

 

 

$-

 

 

$-

 

Alzheimer’s Disease: Therapeutics

 

 

-

 

 

 

4

 

 

 

-

 

Anti-Infectives

 

 

-

 

 

 

-

 

 

 

4

 

BPH (Enlarged Prostate) and Prostate Cancer Therapeutics

 

 

3,370

 

 

 

5,944

 

 

 

7,162

 

Tobacco Exposure Tests: NicAlert™ and TobacAlert™

 

 

-

 

 

 

1

 

 

 

1

 

Total

 

$3,370

 

 

$5,949

 

 

$7,167